Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Filella

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Cytokine|January 8, 2008
Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agentsM Teresa Cibeira, María Rozman, Marta Segarra, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 9, 2008
Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSERafael Molina, Jose Maria Auge, Jose Miguel Escudero, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 25, 2011
HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseasesRafael Molina, Jose M Escudero, Jose M Augé, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 1, 2025
Redefining vitamin D status: Establishing population-based indirect reference intervals through big data analysisAleix B Fabregat-Bolufer, Alba Escolà-Rodríguez, José Luís Bedini-Chesa, et al.
American Heart Journal|November 8, 2002
Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable anginaIgnasi Anguera, Faustino Miranda-Guardiola, Xavier Bosch, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 14, 2011
Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary siteRafael Molina, Xavier Bosch, Josep M Auge, et al.
Critical Care Medicine|April 9, 2004
Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumoniaMalina Ioanas, Miquel Ferrer, Manuela Cavalcanti, et al.
Anticancer Research|October 3, 2018
Relationship Between CA 19.9 and the Lewis Phenotype: Options to Improve Diagnostic EfficiencyMarina Parra-Robert, Víctor Molina Santos, Silvia Miró Canis, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 22, 2024
Factors influencing blood tumor marker concentrations in the absence of neoplasiaJaume Trapé, Esther Fernández-Galán, Josep Maria Auge, et al.
Anticancer Research|February 4, 2019
Serum CA 19.9 Levels in Patients With Benign and Malignant Disease: Correlation With the Serum Protein Electrophoretic PatternSimon Gundín-Menéndez, Victor Molina Santos, Marina Parra-Robert, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Cytokine|January 8, 2008
Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agentsM Teresa Cibeira, María Rozman, Marta Segarra, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 9, 2008
Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSERafael Molina, Jose Maria Auge, Jose Miguel Escudero, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 25, 2011
HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseasesRafael Molina, Jose M Escudero, Jose M Augé, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 1, 2025
Redefining vitamin D status: Establishing population-based indirect reference intervals through big data analysisAleix B Fabregat-Bolufer, Alba Escolà-Rodríguez, José Luís Bedini-Chesa, et al.
American Heart Journal|November 8, 2002
Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable anginaIgnasi Anguera, Faustino Miranda-Guardiola, Xavier Bosch, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 14, 2011
Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary siteRafael Molina, Xavier Bosch, Josep M Auge, et al.
Critical Care Medicine|April 9, 2004
Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumoniaMalina Ioanas, Miquel Ferrer, Manuela Cavalcanti, et al.
Anticancer Research|October 3, 2018
Relationship Between CA 19.9 and the Lewis Phenotype: Options to Improve Diagnostic EfficiencyMarina Parra-Robert, Víctor Molina Santos, Silvia Miró Canis, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 22, 2024
Factors influencing blood tumor marker concentrations in the absence of neoplasiaJaume Trapé, Esther Fernández-Galán, Josep Maria Auge, et al.
Anticancer Research|February 4, 2019
Serum CA 19.9 Levels in Patients With Benign and Malignant Disease: Correlation With the Serum Protein Electrophoretic PatternSimon Gundín-Menéndez, Victor Molina Santos, Marina Parra-Robert, et al.
Pageof 13